Biblio
2015
Hultberg A, Morello V, Huyghe L, De Jonge N, Blanchetot C, Hanssens V, de Boeck G, Silence K, Festjens E, Heukers R, et al. Depleting MET-expressing tumor cells by ADCC provides a therapeutic advantage over inhibiting HGF/MET signaling. Cancer Res. 2015.